With a new year just around the corner, analysts at Piper Jaffray have compiled their top picks for 2016. Dozens of stocks from all sectors made the cut, including Apple Inc. (NASDAQ:AAPL), Novavax, Inc. (NASDAQ:NVAX), Oracle Corporation (NYSE:ORCL), and Starbucks Corporation (NASDAQ:SBUX).

Apple Inc.

Analyst Gene Munster spells out several reasons explains why Apple is a top pick for the New Year. First, he points to the “trend toward annual upgrades in the US,” which will have a favorable revenue impact later in 2016. Over the next four years, the analyst believes that iPhone upgrade cycles will transition to every 15 months, down from the current 22 month average. Munster notes that Apple will roll out the annual upgrade program internationally in the coming year, adding a potential 5% to 7% tailwind. Furthermore, he points to the anticipated iPhone 7 launch in Fall 2016 as a notable catalyst.

Most analysts agree with Munster’s bullish sentiment. Out of the 33 analysts polled by TipRanks, 25 are bullish while 8 remain neutral. The average 12-month price target is $149.41, marking a 34% potential upside from current levels.

Novavax, Inc.

This biotech company made the cut for top stocks of 2016 as Edward Tenthoff explains several catalysts that will drive the stock. Novavax, a biotech company focusing on vaccines, will review full data on its pipeline drugs for both seasonal and pandemic influenza. These endeavors are funded by BARDA (Office of Biomedical Advanced Research and Development Authority) under a $179 million contract. Furthermore, Tenthoff is looking forward to the company’s Phase III RESOLVE trial of RSV-F in elderly patients to fight a respiratory infectious disease.

According to TipRanks, Tenthoff is the only analyst with a recent rating on the company. He has a 50% success rate recommending the company with a +11.9% average return per NVAX call.